300406 九强生物
交易中 12-12 10:14:30
资讯
新帖
简况
九强生物（300406）披露股东拟协议转让部分股份暨权益变动提示性公告，12月10日股价上涨2.89%
证券之星 · 12-10 17:51
九强生物（300406）披露股东拟协议转让部分股份暨权益变动提示性公告，12月10日股价上涨2.89%
九强生物最新公告：取得医疗器械注册证书
证券之星 · 12-09 18:39
九强生物最新公告：取得医疗器械注册证书
九强生物(300406.SZ)取得一项医疗器械注册证
智通财经 · 11-27
九强生物(300406.SZ)取得一项医疗器械注册证
九强生物（300406）披露关于九强转债恢复转股的提示性公告，11月26日股价上涨0.07%
证券之星 · 11-26
九强生物（300406）披露关于九强转债恢复转股的提示性公告，11月26日股价上涨0.07%
九强生物（300406）披露可转债转股价格调整公告，11月24日股价上涨1.59%
证券之星 · 11-24
九强生物（300406）披露可转债转股价格调整公告，11月24日股价上涨1.59%
九强生物（300406）披露关于实施权益分派期间九强转债暂停转股的提示性公告，11月18日股价下跌1.24%
证券之星 · 11-18
九强生物（300406）披露关于实施权益分派期间九强转债暂停转股的提示性公告，11月18日股价下跌1.24%
九强生物最新公告：股东拟减持不超0.38%股份
证券之星 · 11-11
九强生物最新公告：股东拟减持不超0.38%股份
九强生物：肿瘤病理研发投入持续增加
证券之星 · 11-04
九强生物：肿瘤病理研发投入持续增加
九强生物(300406.SZ)取得两项医疗器械注册证
智通财经 · 11-03
九强生物(300406.SZ)取得两项医疗器械注册证
九强生物（300406）2025年三季报简析：净利润同比下降27.03%，公司应收账款体量较大
中金财经 · 10-30
九强生物（300406）2025年三季报简析：净利润同比下降27.03%，公司应收账款体量较大
九强生物（300406）披露全资子公司增持厦门龙进生物科技有限公司股权暨关联交易公告，10月29日股价下跌0.3%
证券之星 · 10-29
九强生物（300406）披露全资子公司增持厦门龙进生物科技有限公司股权暨关联交易公告，10月29日股价下跌0.3%
图解九强生物三季报：第三季度单季净利润同比下降20.96%
证券之星 · 10-29
图解九强生物三季报：第三季度单季净利润同比下降20.96%
九强生物(300406.SZ)取得一项医疗器械注册证书
智通财经 · 10-22
九强生物(300406.SZ)取得一项医疗器械注册证书
九强生物最新公告：取得医疗器械注册证书
证券之星 · 10-20
九强生物最新公告：取得医疗器械注册证书
九强生物（300406）披露取得医疗器械注册证书，10月10日股价上涨0.52%
证券之星 · 10-10
九强生物（300406）披露取得医疗器械注册证书，10月10日股价上涨0.52%
九强生物(300406.SZ)取得医疗器械注册证书
智通财经 · 10-10
九强生物(300406.SZ)取得医疗器械注册证书
股市必读：九强生物（300406）9月26日董秘有最新回复
证券之星 · 09-29
股市必读：九强生物（300406）9月26日董秘有最新回复
股市必读：九强生物（300406）9月25日董秘有最新回复
证券之星 · 09-26
股市必读：九强生物（300406）9月25日董秘有最新回复
九强生物：破解行业痛点、引领技术方向
证券之星 · 09-25
九强生物：破解行业痛点、引领技术方向
9月22日九强生物发布公告，股东增持262.1万股
证券之星 · 09-22
9月22日九强生物发布公告，股东增持262.1万股
加载更多
公司概况
公司名称：
北京九强生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2014-10-30
主营业务：
北京九强生物技术股份有限公司的主营业务是打造多元化、高质量体外诊断检测平台，目前拥有病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统和液体活检系统。公司的主要产品是病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统和液体活检系统。2025年1月14日，公司荣获“军事科学技术进步一等奖”。
发行价格：
14.32
{"stockData":{"symbol":"300406","market":"SZ","secType":"STK","nameCN":"九强生物","latestPrice":13.22,"timestamp":1765505670000,"preClose":13.61,"halted":0,"volume":4694500,"delay":0,"changeRate":-0.0287,"floatShares":424000000,"shares":586000000,"eps":0.7364,"marketStatus":"交易中","change":-0.39,"latestTime":"12-12 10:14:30","open":13.6,"high":13.6,"low":13.18,"amount":62569300,"amplitude":0.0309,"askPrice":13.23,"askSize":324,"bidPrice":13.22,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.7364,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1765510200000},"marketStatusCode":2,"adr":0,"adjPreClose":13.61,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":14.97,"lowLimit":12.25,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":586308628,"isCdr":false,"pbRate":2.09,"roa":"--","peRate":17.9522,"roe":"6.73%","epsLYR":0.92,"committee":0.720047,"marketValue":7751000000,"turnoverRate":0.0111,"status":1,"floatMarketCap":5611000000},"requestUrl":"/m/hq/s/300406","defaultTab":"news","newsList":[{"id":"2590995583","title":"九强生物（300406）披露股东拟协议转让部分股份暨权益变动提示性公告，12月10日股价上涨2.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590995583","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590995583?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:51","pubTimestamp":1765360285,"startTime":"0","endTime":"0","summary":"截至2025年12月10日收盘，九强生物报收于13.88元，较前一交易日上涨2.89%，最新总市值为81.38亿元。该股当日开盘13.8元，最高13.93元，最低13.61元，成交额达1.35亿元，换手率为2.3%。转让完成后，国药投资持股比例由18.49%增至23.49%。本次转让不触及要约收购，不构成关联交易，不会导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000028967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0077","BK0046","BK0028","300406"],"gpt_icon":0},{"id":"2590170953","title":"九强生物最新公告：取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2590170953","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590170953?lang=zh_cn&edition=full","pubTime":"2025-12-09 18:39","pubTimestamp":1765276780,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品包括D-二聚体测定试剂盒（磁微粒化学发光免疫分析法）和D-二聚体测定试剂盒（胶乳免疫比浊法）。这些注册证的取得丰富了公司在体外诊断化学发光及血凝细分领域产品线的品种，有利于提升公司的核心竞争力和市场拓展能力，对公司未来的经营将产生积极影响。但实际销售情况取决于未来市场推广效果，公司目前无法预测其对未来业绩的影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900030082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1583","BK1574","BK1100","BK0077","BK0012","300406","BK1222","09997","BK0239","BK0046","BK0028","159883"],"gpt_icon":0},{"id":"2586217297","title":"九强生物(300406.SZ)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586217297","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586217297?lang=zh_cn&edition=full","pubTime":"2025-11-27 15:48","pubTimestamp":1764229737,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)公告，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品名称为：轻链κ测定试剂盒(免疫比浊法)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK1100","BK1574","BK0028","09997","09996","BK0077","BK1222","BK0012","BK0239","159883","300406","BK1583"],"gpt_icon":0},{"id":"2586263489","title":"九强生物（300406）披露关于九强转债恢复转股的提示性公告，11月26日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586263489","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586263489?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:40","pubTimestamp":1764168021,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，九强生物报收于13.46元，较前一交易日上涨0.07%，最新总市值为78.92亿元。该股当日开盘13.48元，最高13.65元，最低13.38元，成交额达5005.72万元，换手率为0.87%。公司近日发布公告称，因实施2025年第二次中期权益分派，九强转债自2025年11月19日至2025年11月26日暂停转股。根据相关规定，九强转债将于权益分派股权登记日后的第一个交易日，即2025年11月27日起恢复转股。公司提醒债券持有人注意相关安排。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600039235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0077","BK0012","BK0239","300406"],"gpt_icon":0},{"id":"2585849811","title":"九强生物（300406）披露可转债转股价格调整公告，11月24日股价上涨1.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585849811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585849811?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:36","pubTimestamp":1763994990,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，九强生物报收于13.38元，较前一交易日上涨1.59%，最新总市值为78.45亿元。该股当日开盘13.18元，最高13.49元，最低13.11元，成交额达5356.45万元，换手率为0.95%。公司近日发布公告称，因实施2025年第二次中期权益分派，向全体股东每10股派发现金2.000000元人民币（含税），根据可转债转股价格调整条款，对“九强转债”转股价格进行调整。调整后转股价格由16.68元/股下调至16.48元/股，自2025年11月27日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400036241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300406","BK0077","BK0046","BK0012","BK0028"],"gpt_icon":0},{"id":"2584933747","title":"九强生物（300406）披露关于实施权益分派期间九强转债暂停转股的提示性公告，11月18日股价下跌1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584933747","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584933747?lang=zh_cn&edition=full","pubTime":"2025-11-18 18:03","pubTimestamp":1763460223,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，九强生物报收于13.51元，较前一交易日下跌1.24%，最新总市值为79.21亿元。该股当日开盘13.72元，最高13.74元，最低13.5元，成交额达5057.21万元，换手率为0.88%。近日，九强生物发布关于实施权益分派期间九强转债暂停转股的提示性公告。公告称，北京九强生物技术股份有限公司将于2025年实施第二次中期权益分派，根据相关规定，九强转债自2025年11月19日起至权益分派股权登记日止暂停转股，股权登记日后的第一个交易日起恢复转股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800028346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0077","300406","BK0012","BK0239"],"gpt_icon":0},{"id":"2582654073","title":"九强生物最新公告：股东拟减持不超0.38%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2582654073","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582654073?lang=zh_cn&edition=full","pubTime":"2025-11-11 19:59","pubTimestamp":1762862376,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称，持股5%以上的自然人股东ZHOUXIAOYAN计划自公告披露之日起十五个交易日后的三个月内，通过集中竞价和/或大宗交易方式减持公司股份不超过221.42万股（占公司总股本的0.38%），减持原因为自身资金需求。减持期间为公告披露之日起十五个交易日后的三个月内（即2025年12月3日至2026年3月2日）。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100035829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406","BK0028","BK0046","BK0239","BK0012","BK0077"],"gpt_icon":0},{"id":"2580527299","title":"九强生物：肿瘤病理研发投入持续增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2580527299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580527299?lang=zh_cn&edition=full","pubTime":"2025-11-04 11:33","pubTimestamp":1762227188,"startTime":"0","endTime":"0","summary":"证券之星消息，九强生物(300406)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，贵司在肿瘤病理研发方面有没有增加投入资金？九强生物回复：您好，感谢您对公司的关注。肿瘤病理是我们长期聚焦的核心战略方向。近年来公司在该领域的研发投入持续增加，以巩固我们在肿瘤诊断领域的领先地位，并推动创新成果的临床转化。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400014493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0077","300406","BK0012","BK0239"],"gpt_icon":0},{"id":"2580129261","title":"九强生物(300406.SZ)取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2580129261","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580129261?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:53","pubTimestamp":1762156397,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)公告，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品名称分别为：肝素结合蛋白测定试剂盒(磁微粒化学发光免疫分析法)、全自动生化分析仪(型号：Gc2000、Gc2400)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","300406","BK1583","09997","BK0046","BK1222","BK0012","BK1100","BK0077","159883","BK0028","BK0239","09996"],"gpt_icon":0},{"id":"2579715623","title":"九强生物（300406）2025年三季报简析：净利润同比下降27.03%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2579715623","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579715623?lang=zh_cn&edition=full","pubTime":"2025-10-30 08:06","pubTimestamp":1761782764,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期九强生物发布2025年三季报。截至本报告期末，公司营业总收入10.12亿元，同比下降18.24%，归母净利润2.72亿元，同比下降27.03%。按单季度数据看，第三季度营业总收入3.43亿元，同比下降17.39%，第三季度归母净利润9722.7万元，同比下降20.96%。本报告期九强生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达192.14%。然而去年的净利率为32.02%，算上全部成本后，公司产品或服务的附加值极高。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202510/30/20251030441913.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202510/30/20251030441913.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251030/31748835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300406"],"gpt_icon":0},{"id":"2579923973","title":"九强生物（300406）披露全资子公司增持厦门龙进生物科技有限公司股权暨关联交易公告，10月29日股价下跌0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579923973","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579923973?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:53","pubTimestamp":1761731593,"startTime":"0","endTime":"0","summary":"九强生物近日发布公告称，公司全资子公司福州迈新生物技术开发有限公司拟以自有资金3,529.80万元收购厦门龙进生物科技有限公司22.27%股权，对应注册资本530.00万元。本次交易完成后，迈新生物将持有龙进生物47.48%股权。本次交易构成关联交易，已获公司第五届董事会第二十一次会议及独立董事专门会议审议通过，无需提交股东大会审议。公司与龙进生物本年年初至公告日累计发生关联交易653,006.72元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900037642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","159837","BK0046","BK0077","BK0239","BK0028","300406"],"gpt_icon":0},{"id":"2579995922","title":"图解九强生物三季报：第三季度单季净利润同比下降20.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579995922","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579995922?lang=zh_cn&edition=full","pubTime":"2025-10-29 03:12","pubTimestamp":1761678779,"startTime":"0","endTime":"0","summary":"证券之星消息，九强生物2025年三季报显示，公司主营收入10.12亿元，同比下降18.24%；归母净利润2.72亿元，同比下降27.03%；扣非净利润2.7亿元，同比下降27.21%；其中2025年第三季度，公司单季度主营收入3.43亿元，同比下降17.39%；单季度归母净利润9722.7万元，同比下降20.96%；单季度扣非净利润9672.55万元，同比下降21.42%；负债率24.55%，投资收益-104.27万元，财务费用3104.49万元，毛利率79.86%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900003382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406"],"gpt_icon":0},{"id":"2577935592","title":"九强生物(300406.SZ)取得一项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2577935592","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577935592?lang=zh_cn&edition=full","pubTime":"2025-10-22 15:50","pubTimestamp":1761119400,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品名称：地高辛测定试剂盒(磁微粒化学发光免疫分析法)，该试剂盒用于体外定量测定人血清或血浆中地高辛(DIG)的含量。上述产品医疗器械注册证的取得，丰富了公司在体外诊断化学发光细分领域产品线的品种，有利于进一步提升公司的核心竞争力和市场拓展能力，对公司未来的经营将产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0239","BK1583","09996","09997","BK1100","BK0077","BK0046","BK0028","BK1222","300406","159883","BK1574"],"gpt_icon":0},{"id":"2576834398","title":"九强生物最新公告：取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2576834398","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576834398?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:57","pubTimestamp":1760950670,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称，公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品为N末端脑利钠肽前体测定试剂盒（磁微粒化学发光免疫分析法），注册证编号为京械注准20252400875，有效期至2030年10月14日。该试剂盒用于体外定量测定人血清或血浆中N末端脑利钠肽前体（NT-proBNP）的含量。该注册证的取得丰富了公司产品类别，有利于增强公司的核心竞争力，对公司未来发展具有正面影响，但对近期的生产经营和业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000020716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0028","BK1583","BK0046","BK1222","BK0239","159883","BK0077","09997","BK0012","09996","300406","BK1100"],"gpt_icon":0},{"id":"2574771041","title":"九强生物（300406）披露取得医疗器械注册证书，10月10日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574771041","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574771041?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:48","pubTimestamp":1760107702,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，九强生物报收于13.51元，较前一交易日上涨0.52%，最新总市值为79.21亿元。注册类别均为Ⅱ类，有效期均至2030年9月27日或28日。上述产品分别用于体外定量测定人尿液中转铁蛋白、人血清或血浆中纤维连接蛋白、人血清中铜的含量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0046","BK0028","BK1100","BK0077","BK1222","BK1574","09996","300406","159883","BK0012","09997","BK0239"],"gpt_icon":0},{"id":"2574567128","title":"九强生物(300406.SZ)取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2574567128","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574567128?lang=zh_cn&edition=full","pubTime":"2025-10-10 15:47","pubTimestamp":1760082473,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品名称分别为：尿转铁蛋白测定试剂盒(胶乳免疫比浊法)、纤维连接蛋白测定试剂盒(免疫比浊法)、铜测定试剂盒(PAESA显色剂法)、纤维连接蛋白测定试剂盒(免疫比浊法)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300406","09996","BK1100","BK0012","159883","09997","BK0046","BK0028","BK0077","BK1222","BK1583","BK1574"],"gpt_icon":0},{"id":"2571821517","title":"股市必读：九强生物（300406）9月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2571821517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571821517?lang=zh_cn&edition=full","pubTime":"2025-09-29 03:28","pubTimestamp":1759087694,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，九强生物报收于13.38元，下跌0.45%，换手率0.49%，成交量2.08万手，成交额2781.54万元。交易信息汇总资金流向9月26日主力资金净流出124.69万元；游资资金净流入22.66万元；散户资金净流入102.03万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900001291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0012","BK0239","300406","BK0077"],"gpt_icon":0},{"id":"2570010968","title":"股市必读：九强生物（300406）9月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570010968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570010968?lang=zh_cn&edition=full","pubTime":"2025-09-26 01:19","pubTimestamp":1758820752,"startTime":"0","endTime":"0","summary":"截至2025年9月25日收盘，九强生物报收于13.44元，下跌0.88%，换手率0.61%，成交量2.58万手，成交额3485.81万元。董秘最新回复投资者： 注意到近期公司在自己的公众号上发布一些公司的新品。这种宣传途径是好的。证明公司刚拿到的注册证产品就要和100多家公司进行竞争。行业、公司要往前发展必须要解决当下有但是还没解决的问题。当日关注点来自交易信息汇总：9月25日主力资金净流出129.67万元，游资资金净流入226.04万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600000581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0046","BK0028","BK0077","300406"],"gpt_icon":0},{"id":"2570062492","title":"九强生物：破解行业痛点、引领技术方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2570062492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570062492?lang=zh_cn&edition=full","pubTime":"2025-09-25 16:45","pubTimestamp":1758789917,"startTime":"0","endTime":"0","summary":"证券之星消息，九强生物09月25日在投资者关系平台上答复投资者关心的问题。行业、公司要往前发展必须要解决当下有但是还没解决的问题。因此公司始终将 “破解行业痛点、引领技术方向” 作为核心发展目标，期待与您共同见证公司未来的突破。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500024154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0077","BK0046","BK0028","300406"],"gpt_icon":0},{"id":"2569083783","title":"9月22日九强生物发布公告，股东增持262.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2569083783","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569083783?lang=zh_cn&edition=full","pubTime":"2025-09-22 18:04","pubTimestamp":1758535468,"startTime":"0","endTime":"0","summary":"证券之星消息，9月22日九强生物发布公告《九强生物:关于公司持股5%以上股东增持公司股份计划实施期限过半的公告》，其股东中国医药投资有限公司于2025年6月23日至2025年9月22日间合计增持262.1万股，占公司目前总股本的0.447%，变动期间该股股价上涨0.3%，截止9月19日收盘报13.5元。股东增减持详情见下表：根据九强生物2025年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200024560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0239","BK0012","300406","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765505674607,"stockEarnings":[{"period":"1week","weight":0.0015},{"period":"1month","weight":-0.0112},{"period":"3month","weight":-0.0083},{"period":"6month","weight":0.0492},{"period":"1year","weight":-0.0318},{"period":"ytd","weight":0.0871}],"compareEarnings":[{"period":"1week","weight":-0.0006},{"period":"1month","weight":-0.0323},{"period":"3month","weight":0.0007},{"period":"6month","weight":0.147},{"period":"1year","weight":0.1284},{"period":"ytd","weight":0.1556}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京九强生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18058人(较上一季度减少2.48%)","perCapita":"23502股","listingDate":"2014-10-30","address":"北京市海淀区花园东路15号旷怡大厦5层","registeredCapital":"58630万元","survey":" 北京九强生物技术股份有限公司的主营业务是打造多元化、高质量体外诊断检测平台，目前拥有病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统和液体活检系统。公司的主要产品是病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统和液体活检系统。2025年1月14日，公司荣获“军事科学技术进步一等奖”。","listedPrice":14.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九强生物,300406,九强生物股票,九强生物股票老虎,九强生物股票老虎国际,九强生物行情,九强生物股票行情,九强生物股价,九强生物股市,九强生物股票价格,九强生物股票交易,九强生物股票购买,九强生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}